Member Info for Morgank

Something happening here now over 10m

9 mil so far today mostly buys

Some large buys continuing from yesterday

There are two 3.1 trades showing now around the same time but second not showing as negative (cancelled trade)
Another mystery

Are we getting close to a fall ?

FinnCap reiterate SP target 135p

http://investing.thisismoney.co.uk/broker-views/

I have been monitoring AGL’s other listing ‘ANPCY’ which is referenced on their website, for weeks its not moved but yesterday a 7.4% jump to 9.0 vol was only 200 but as not trades on this market since April may be significant !

The Company has also established a Level 1 ADR Program in the US and ADRs are traded on the OTCQX Market (OTCQX: ANPCY).
https://www.otcmarkets.com/stock/ANPCY/quote

Looks like Jupiter have increased their holding or maybe just maintained their % holding, have to see what RNS’s on holdings transpire.
The funding question is out the way now

It shows the institutional demand for this stock taking it at no discount to market price, ok 17% more stock in issue but hope by end of today all sold @61.5p
Now funding is clear SP is responding with great prospects to come

1m just sold in 3 trades, almost like two markets going on in SEE, continued selling which ok someone is buying @ 3.2 ish and then occasional trades in the blue upto 3.25
3 trades @ 3.2055 were sells based on by buy / sell checks.
Seems at the moment you can sell whatever for 3.2, so is someone building a stake, not reported though

Let’s hope Red have a plan when Finals announced tomorrow GLA !

Last year final results out on 25 July, notified on 2 July.
Fund raise was last week in June last year, but 14m in cash end Oct should be ok.

Go to be tempting to one of them now as so much positive research completed now with positive results each time

Funny how the SP plunged yesterday and the little guy gets shafted again

Extract

Angle PLC Parsortix used to investigate immunotherapy target

Source: UK Regulatory (RNS & others)
TIDMAGL

RNS Number : 9644C

Angle PLC

21 June 2019


For immediate release 21 June 2019

LEADING CANCER CENTRE DEMONSTRATES USE OF PARSORTIX AS A LIQUID BIOPSY TO INVESTIGATE KEY IMMUNOTHERAPY TARGET IN LUNG CANCER

Potential for use of Parsortix as treatment selection biomarker in assessing patient response to cancer immunotherapy drugs with revenues forecast to exceed US$ 20 billion this year

Well 1mil sell just hit the tape

The 50% increase in share issue really put a damper on SP expectations , it will take an awful lot to move the needle now.

This stock just sells off day after day, seems to be a floor @3.20 but for how long, the SP has fallen back this week.

I cant understand if its a DMS gold rush, were are the buyers ?

I guess someone has to be buying @ 3.2 but who ??

Still worrying questions, approaching year end again !

Good find, still think Angle could be taken out before FDA approval , they are delivering on what they set out to do

https://twitter.com/Scott__McGregor/status/1139164786179149825?s=20